期刊文献+

替格瑞洛在急性冠脉综合征治疗中的应用观察 被引量:2

下载PDF
导出
摘要 目的探讨替格瑞洛治疗急性冠状动脉综合征(急性冠脉综合征)的临床效果。方法 88例急性冠脉综合征患者,随机分成观察组和对照组,各44例。观察组患者采用替格瑞洛进行治疗,对照组患者采用氯吡格雷进行治疗,比较两组治疗效果。结果对照组患者手术中出现3例急性血栓,发生率为6.8%,观察组无一例患者出现急性血栓,两组比较差异有统计学意义(P<0.05);经治疗后,观察组患者不良心血管事件发生率为4.5%,明显低于对照组的25.0%,差异有统计学意义(P<0.05)。结论对急性冠脉综合征患者在常规治疗的基础上加用替格瑞洛进行治疗可以取得显著效果,值得临床推广。
作者 朱炜
出处 《中国实用医药》 2016年第28期222-223,共2页 China Practical Medicine
  • 相关文献

参考文献8

二级参考文献93

  • 1葛均波,徐永健.内科学.第8版.北京:人民卫生出版社,2013:553-556.
  • 2Anderson SD, Shah NK, Yim J, et al. Efficacy and safety of ti- cagrelor : a reversible P2Y12 receptor antagonist[ J]. AnnPharmaco- ther,2010,44 : 524-537.
  • 3Antman EM, Hand M, Armstrong PW, et ai,2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guide- lines[J]. J Am Coil Cardiol,2008,51 : 210-247.
  • 4Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guide- lines for the management of patients with unstable angina/non-ST-Ele- vation myocardial infarction : a report of the American College of Cardi- ology[J]. J Am Coll Cardiol,2007,50: e1-e157.
  • 5Steg PG, Harrington RA, Emanuelsson H, et al. Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syn- dromes: an analysis from the prospective, randomized PLATO trial [J].Circulation, 2013, 128: 1055-1065.
  • 6James S, Akerblom A, Cannon CP, et al. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes : rationale, design, and baseline characteristics of the platelet inhibition and patient Outcomes ( PEA-TO) trial[J]. Am Heart J,2009,157: 599-605.
  • 7Cheng JWM. Ticagrelor: oral reversible P2Y ( 12 ) receptor antagonist for the management of acute coronary syndromes [ J ]. Clin Ther,2012, 34(6) :1209-1220.
  • 8Jeong YH, Bliden KP, Antonino M J, et al. Usefulness of the Veri- fyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies[ J]. Am Heart J, 2012, 164: 35-42.
  • 9Yarenhorst C, Alstrom U, Scirica BM, et al. Factors contributing to the lower mortality with ticagrelor compared with clopidagrel in patients undergoing coronary artery bypass surgery [ J ]. J Am Coil Cardiol, 2012, 60 : 1623-1630.
  • 10Lee CWo Dual antiplatelet therapy for coronary artery disease. CircJ .2015.79:255-262.

共引文献44

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部